• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有孤立性小眼畸形的LRP5相关性骨质疏松-假性神经胶质瘤综合征

LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.

作者信息

Ergun Sezen Guntekin, Akay Guvem Gumus, Ergun Mehmet Ali, Perçin E Ferda

机构信息

Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey; Gazi University Faculty of Medicine, Department of Medical Genetics, Besevler, Ankara, Turkey.

Brain Research Centre, Ankara University, Mamak, Ankara, Turkey.

出版信息

Eur J Med Genet. 2017 Mar;60(3):200-204. doi: 10.1016/j.ejmg.2017.01.007. Epub 2017 Jan 19.

DOI:10.1016/j.ejmg.2017.01.007
PMID:28111184
Abstract

Microphthalmia is defined as the measurement of the total axial length of the eyeball to be below average of the two standard deviation according to the age. While several genes have been identified so far related to microphthalmia, the genetic etiology of the disease has not been fully understood because of genetic heterogeneity observed in this disease. After exclusion of the genes that had been known to be the cause of microphthalmia, we performed homozygosity mapping and exome sequencing to clarify the genetic etiology of the bilateral microphthalmia in this family. When the results of the exome and microarray data were considered together as a splice-site mutation in LRP5 gene [c.2827 + 1G > A], which is known to be important for eye development and Wnt receptor signaling pathway, was found to be the cause of microphthalmia in our family. It was understood that after finding this mutation, when bone mineral density was measured with DXA in the family whose ages range between 19 and 28 and who have no bone problem before, osteoporosis was diagnosed. It was also understood that microphthalmia found in this family is a clinical finding of OPPG syndrome.

摘要

小眼症的定义是根据年龄,眼球总眼轴长度的测量值低于平均水平两个标准差。虽然目前已经鉴定出几个与小眼症相关的基因,但由于该疾病存在遗传异质性,其遗传病因尚未完全明确。在排除已知导致小眼症的基因后,我们进行了纯合子定位和外显子组测序,以明确该家族双侧小眼症的遗传病因。当将外显子组和微阵列数据的结果综合考虑时,发现LRP5基因中的一个剪接位点突变[c.2827 + 1G > A]是我们家族中小眼症的病因,已知该基因对眼睛发育和Wnt受体信号通路很重要。据了解,发现该突变后,在年龄介于19至28岁且此前无骨骼问题的家族成员中,通过双能X线吸收法(DXA)测量骨密度时,诊断出了骨质疏松症。还了解到该家族中发现的小眼症是骨质疏松 - 假性神经胶质瘤综合征(OPPG综合征)的一个临床症状。

相似文献

1
LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.伴有孤立性小眼畸形的LRP5相关性骨质疏松-假性神经胶质瘤综合征
Eur J Med Genet. 2017 Mar;60(3):200-204. doi: 10.1016/j.ejmg.2017.01.007. Epub 2017 Jan 19.
2
Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.患有骨质疏松-假性神经胶质瘤综合征的墨西哥患者中的新型LRP5纯合突变
Genet Test Mol Biomarkers. 2017 Dec;21(12):742-746. doi: 10.1089/gtmb.2017.0118. Epub 2017 Nov 13.
3
Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.OPPG 和高骨量疾病的临床特征、治疗和随访:LRP5 是骨量的关键调节因子。
Osteoporos Int. 2024 Aug;35(8):1395-1406. doi: 10.1007/s00198-024-07080-x. Epub 2024 Apr 16.
4
Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.骨质疏松-假瘤综合征:希腊 10 例新病例的临床、遗传和治疗反应研究。
Eur J Pediatr. 2019 Mar;178(3):323-329. doi: 10.1007/s00431-018-3299-3. Epub 2018 Nov 29.
5
Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.LRP5 基因突变通过降低 Wnt 信号活性导致不伴有 OI 特征的原发性骨质疏松症。
BMC Med Genet. 2012 Apr 10;13:26. doi: 10.1186/1471-2350-13-26.
6
Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.骨质疏松-假瘤综合征:LRP5 基因中的三个新突变及双膦酸盐治疗的反应。
Horm Res Paediatr. 2012;77(2):115-20. doi: 10.1159/000336193. Epub 2012 Mar 23.
7
Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.通过改变WNT信号活性逆转LRP5依赖性骨质疏松症和SOST缺乏引起的硬化性骨疾病。
J Bone Miner Res. 2014 Jan;29(1):29-42. doi: 10.1002/jbmr.2059.
8
Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome.两名患有骨质疏松-假性胶质瘤综合征的兄弟姐妹中的先天性双侧视网膜脱离
Ophthalmic Genet. 2015;36(3):276-80. doi: 10.3109/13816810.2015.1016240.
9
Exploiting the WNT Signaling Pathway for Clinical Purposes.将WNT信号通路用于临床目的。
Curr Osteoporos Rep. 2017 Jun;15(3):153-161. doi: 10.1007/s11914-017-0357-0.
10
Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.四位新患者的骨质疏松-假瘤综合征:两种新 LRP5 变异的鉴定及双膦酸盐治疗患者管理的见解。
Osteoporos Int. 2022 Jul;33(7):1501-1510. doi: 10.1007/s00198-022-06313-1. Epub 2022 Feb 1.

引用本文的文献

1
The ROS/CaMK II/β-Catenin Signaling Axis Affects the Osteogenic Potential of BMSCs and Disrupts Implant Osseointegration: An In Vitro Study.ROS/CaMK II/β-连环蛋白信号轴影响骨髓间充质干细胞的成骨潜能并破坏种植体骨整合:一项体外研究
Int J Dent. 2025 Aug 15;2025:5566776. doi: 10.1155/ijod/5566776. eCollection 2025.
2
Optic cup morphogenesis across species and related inborn human eye defects.视杯形态发生的跨物种研究及其与相关人类先天眼缺陷的关系。
Development. 2023 Jan 15;150(2). doi: 10.1242/dev.200399. Epub 2023 Jan 30.
3
Effects of Stress on Osteoblast Proliferation and Differentiation Based on Endoplasmic Reticulum Stress and Wnt-Catenin Signaling Pathway.
基于内质网应激和 Wnt-连环蛋白信号通路的应激对成骨细胞增殖和分化的影响。
Contrast Media Mol Imaging. 2022 Sep 19;2022:8521051. doi: 10.1155/2022/8521051. eCollection 2022.
4
Exome sequencing identifies genetic variants in anophthalmia and microphthalmia.外显子组测序鉴定出无眼症和小眼症的遗传变异。
Am J Med Genet A. 2022 Aug;188(8):2376-2388. doi: 10.1002/ajmg.a.62874. Epub 2022 Jun 18.
5
Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.四位新患者的骨质疏松-假瘤综合征:两种新 LRP5 变异的鉴定及双膦酸盐治疗患者管理的见解。
Osteoporos Int. 2022 Jul;33(7):1501-1510. doi: 10.1007/s00198-022-06313-1. Epub 2022 Feb 1.